期刊文献+

凝固酶阴性葡萄球菌分布及耐药变迁 被引量:4

Drug-resistance of coagulase negativeStaphylococcus isolated clinically in our hospital these years
下载PDF
导出
摘要 目的探讨凝固酶阴性葡萄球菌(CNS)感染分布及其耐药趋势与变迁,为临床治疗CNS感染提供正确选药依据。方法收集本院2001~2003年484株CNS与2004~2007年间512株CNS进行对比分析,采用Kirby-Bauer法进行药敏试验,高盐琼脂扩散法对苯唑西林耐药的菌株作耐甲氧西林葡萄球菌(MRS)测定,按临床实验室标准化委员会(CLLSI/LNCCLS)2007年标准判断结果。结果996株凝固酶阴性葡萄球菌中,未发现万古霉素耐药菌株,分别对青霉素、红霉素、苯唑青霉素、阿莫西林/克拉维酸、克林霉素、头孢唑啉、头孢曲松、头孢吡肟等抗生素耐药率均大于70%;两组比较差异有统计学意义(P<0.05);对利福平、呋喃妥因、阿米卡星、四环素、复方新诺明耐药率均小于50%,差异无统计学意义(P>0.05)。结论近3年临床分离的CNS耐药谱与前3年相比,有很大的改变。临床医生应根据实验室药敏结果,合理使用抗生素,有效控制凝固酶阴性葡萄球菌的感染。 Objective To investigate the distribution and the characteristics of drug resista-nce of coagulase negative Staphylococcus, and to provide the reference for properly choosi-ng antibiotic therapy of coagulase negative Staphylococcal infecs. Methods Contrasted 484 coagulase negative Staphylococcus (CNS) species isolated in hospital from 2001 to 2003 and 512 species from 2004 to 2007. Nosocomial CNS was identified and then drug resistance test was performed by K-B method , Nitrocefin method was utilized to delect β-lactamase. Clinical and Laboratory Standards Institute. Perfor-mance Standards forantimicro bial susceptibility testing; Fifteenth information supplement. CLSI/ NCCLS document M100- S17[J]. Clinical and Laboratory Standards. Results The drug-resistant rate of . CNS to penicillin, erythromycin, oxacillin, amoxicillin/elavulanate, clindamycin, cepzolin, eeftriaxone and cefepime was high ( 〉 70 % ), whereas that to rifampin, nitrofurantoin, amikacin, tetracycline and trimethop-rim/sulfamethoxazole was low(〈50% ). No drug-resistant CNS strains to vancomycin weta found. Conclusions,and no outstanding imparity from two groups. Conclusion The pattern of resistance has changed greatly in the past 3 years. Clinical physicians should pay attention to properly choosing and using antibiotics.
作者 李霞
出处 《国际检验医学杂志》 CAS 2008年第12期1101-1103,共3页 International Journal of Laboratory Medicine
关键词 葡萄球菌属 凝固酶 抗药性 细菌 Staphylococcus Coagulase Drug Resistance, Bacterial
  • 相关文献

参考文献6

二级参考文献16

  • 1郭晨雯,范春,牛其昌,傅金英,王颖.1999~2003年铜绿假单胞菌耐药性变迁的分析[J].中华医院感染学杂志,2005,15(8):940-942. 被引量:45
  • 2周薇薇,白立彦,张秀菊,杨云海.耐亚胺培南铜绿假单胞菌的分布及耐药性分析[J].中华医院感染学杂志,2005,15(10):1184-1186. 被引量:38
  • 3[1] Froggatt J W,Johnston J L,Galetto D W,et al.Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus[J].Antimicro bial Agents chemother,1989,33∶460?466.
  • 4[2] Burriel A R.In vivo presence of capsular polysaccharide in coagulasenegative staphylococci of ovine origin[J].New Microbiol,1998,21∶49?54.
  • 5[3] Fujita K,Yokota T,Oguri Y,et al.In vitro adherence of Staphylococcus saprophyticus,Staphylococcus haemolyticus,and Staphylococcus aureus to human ureter[J].Urol Res,1991,20∶399?402.
  • 6[4] Molonar C, Hevessy Z,Rozgonyi F,et al.Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence,hydrophobicity,and toxin producution in vitro[J].J Clin Pathol,1994,47∶743?748.
  • 7[5] Schwalbe R S,Ritz W J,Verma P R,et al.Selection for vancomycin reststance in clinical isolates of Staphylococcus haemolyticus[J].J Infect Dis,1990,161∶45?51.
  • 8[6] Utili R,Tripodi M F,Rosario P,et al.Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin[J].New Microbiol,1996,19∶309-314.
  • 9洪秀华.临床微生物学[M].北京:中国医药科学技术出版社,2004.180.
  • 10NCCLS.Performance standards for antimicrobial susceptibility testing[S].Ninth informational supplement.M100-S9.NCCLS,1999.19(1) :40.

共引文献102

同被引文献36

  • 1骆俊,吴菊芳.血流感染诊断及治疗进展[J].中国抗感染化疗杂志,2005,5(2):119-123. 被引量:29
  • 2CHAN Khee-siang,YU Wen-liang,TSAI Chi-lun,CHENG Kuo-chen,HOU Ching-cheng,LEE Meng-chih,TAN Che-kim.Pyogenic liver abscess caused by Klebsiella pneumoniae:analysis of the clinical characteristics and outcomes of 84 patients[J].Chinese Medical Journal,2007(2):136-139. 被引量:27
  • 3Boueher HW, Talbot GH, Bradley JS, Edwards JE, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America[ J ]. Clin Infect Dis, 2009, 48 ( 1 ) : 1- 12.
  • 4Sader HS, Flamm RK, Jones RN. Antimicrobial activity of dapto- mycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011) [J]. Diagn Microbiol Infect Dis, 2013, 75: 417422.
  • 5Rodrfguez-Cr6ixems M, Alcali L, Mufioz P, et al. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006 [ J]. Medicine, 2008, 87 (4) : 234-249. DOI: 10. 1097/MD. 0b013e318182119b.
  • 6Laupland KB, Zygun DA, Davies HD, et al. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate [J]. Crit Care Med, 2002, 30(11) : 2462-2467.
  • 7Aslan O, Afsar I, Demir M,et al. Procalcitonin and C-reactive protein levels according to blood culture results in intensive care unit patients[J]. Infect Dis Clin Practice, 2014, 22(5): 267- 270. DOI:10. 3760/cma. j. issn. 2095-4352. 2014. 03. 008.
  • 8Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock, 2012[J]. Intens Care Med, 2013, 41 (2) : 580-637. DOI: 10. 1097/CCM. 0b013e31827e83af.
  • 9郑宇琼,陈淑贞.2005~2007年临床分离大肠埃希菌耐药性分析[J].中国热带医学,2009,9(1):197-198. 被引量:2
  • 10刘媚娜,吴庆,刘庆中,周武,周铁丽.金黄色葡萄球菌临床分布及耐药性分析[J].现代实用医学,2009,21(1):43-44. 被引量:9

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部